37 results
6-K
BYSI
BeyondSpring Inc
10 Jan 24
Current report (foreign)
3:00pm
or procedure, which disagreements, if not resolved to the satisfaction of EY, would have caused EY to make reference to the subject matter
6-K
EX-99.2
kuge d5ks4
9 Feb 21
Current report (foreign)
9:21am
6-K
EX-1.1
5q2b7q5fmaj
23 Nov 20
Current report (foreign)
4:16pm
424B5
2zlpvek 4reh
19 Nov 20
Prospectus supplement for primary offering
4:12pm
424B5
68tc4
17 Nov 20
Prospectus supplement for primary offering
4:19pm
6-K
3jpjn6p
13 Nov 20
BeyondSpring Subsidiary, Seed Therapeutics, Announces Research Collaboration and License Agreement with Lilly
7:28am
6-K
wf4onevv11snygqov09h
23 Jun 20
Current report (foreign)
4:09pm
6-K
EX-1.1
5fet3xij 4a
23 Jun 20
Current report (foreign)
4:09pm
424B5
7trab07s
19 Jun 20
Prospectus supplement for primary offering
4:31pm
424B5
wdlr1uzvsfd06m4
18 Jun 20
Prospectus supplement for primary offering
4:40pm
6-K
EX-1.1
om3ey
29 Oct 19
Current report (foreign)
4:05pm
424B5
95yr63n07e oxo
28 Oct 19
Prospectus supplement for primary offering
4:02pm
424B5
pb1jgumc54 6pzs
25 Oct 19
Prospectus supplement for primary offering
12:00am